SelectQuote Faces Class Action Lawsuit
Glancy Prongay & Murray LLP recently announced the filing of a class action lawsuit in the United States District Court for the Southern District of New York on behalf of investors who purchased shares of SelectQuote, Inc. (SLQT) within a specific timeframe. This legal action underscores serious allegations of securities fraud that have raised concerns among stakeholders about the company's practices and its implications on investor finances.
Key Details of the Lawsuit
The case, entitled Pahlkotter v. SelectQuote, Inc., et al., involves claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lawsuit details that individuals and entities who acquired SelectQuote securities between September 9, 2020, and May 1, 2025, inclusive, potentially faced misleading disclosures about the company’s operations and financial health.
What Led to the Class Action?
On May 1, 2025, significant developments unfolded when the U.S. Department of Justice filed a complaint accusing SelectQuote of violating the False Claims Act. Allegations indicated that the company engaged in inappropriate practices, including accepting illicit kickbacks from health insurance companies in exchange for directing Medicare beneficiaries towards specific plans. This act of steering clients, regardless of the quality of coverage, raised substantial ethical questions and potentially put vulnerable populations at risk.
Impact of Allegations on Stock Performance
News of the DOJ's complaints sent shockwaves through the market. Following these revelations, SelectQuote's stock price experienced a significant plummet, decreasing by 19.2% to close at $2.56. This sharp decline not only reflects investor reactions to the allegations but also raises further questions about the company's future and the reliability of its earlier claims regarding unbiased insurance comparisons.
Nature of the Allegations
The class action alleges that throughout the class period, SelectQuote’s executives made misleading statements about the company’s business model and the integrity of its operations. Key points of contention include the following:
- Misrepresentations about the nature of coverage comparisons provided to customers.
- Failure to disclose that Medicare beneficiaries were being directed towards plans that financially benefited SelectQuote rather than serving the customers' best interests.
- Acceptance of kickbacks that contravened federal laws, putting the company at risk for regulatory penalties.
- Assurances given to investors were deemed misleading as facts regarding potential regulatory sanctions were not adequately disclosed.
Next Steps for Affected Investors
For those who may have suffered financial losses due to these recent developments, it is crucial to consider your options moving forward. Investors have a 60-day window from receiving this notice to apply to serve as lead plaintiff in the ongoing class action litigation.
Get Involved
Individuals looking to learn more about this lawsuit or seeking assistance with potential claims against SelectQuote are encouraged to reach out. Contact Charles Linehan at Glancy Prongay & Murray LLP, located at 1925 Century Park East, Suite 2100, Los Angeles, CA 90067, or via email at shareholders@glancylaw.com for further guidance.
Frequently Asked Questions
What is SelectQuote being accused of?
SelectQuote is facing allegations related to accepting illegal kickbacks from insurance companies and directing Medicare beneficiaries to subpar insurance plans for profit.
Who can be a lead plaintiff in the class action?
Affected investors who purchased SelectQuote shares during the designated class period can apply to serve as lead plaintiff.
What are the financial implications for investors?
Investors may face significant financial impacts due to stock price declines if the allegations prove substantiated.
How can I find out if I am part of the class?
If you purchased SelectQuote securities between the specified dates, you are likely part of the class. It is advisable to seek legal counsel for clarity on your status.
Where can I find more information on this lawsuit?
Investors can contact Glancy Prongay & Murray LLP or monitor updates through official communications regarding the case.
